Hormonal Imbalances and Metabolic Syndrome
Metabolic syndrome is characterized by central obesity, dyslipidemia, hypertension, and hyperglycemia, with hormonal dysregulation as a key driver. Insulin, cortisol, thyroid hormones, and sex hormones significantly influence metabolic homeostasis. Imbalances in these endocrine systems exacerbate obesity and increase cardiometabolic risk. Clinical management requires integrated approaches combining pharmacological therapy, lifestyle modification, and targeted hormone interventions. Advances in endocrinology and metabolic research are refining strategies to identify at-risk individuals early and to optimize therapeutic outcomes through precision approaches.